摘要
目的评价个体化健康管理方式对肝移植术后患者长期存活及生存质量的影响。方法回顾性分析2006年1月至2009年1月在我中心随访调查的肝移植术后患者共374例。所有患者均签署知情同意书,研究符合伦理规定及要求。将374例患者随机分为个体化健康管理实验组和常用药物治疗对照组,实验组在随访过程中采用个体化健康管理方式干预,对照组不进行干预;比较两组不良事件发生率。结果两组患者不良事件的发生率差异具有统计学意义(17.4%比52.2%,χ2=8.326,P<0.05)。结论个体化健康管理方式能更好地提高肝移植术后患者的存活率和生活质量。
Objective To evaluate the effect of individualized health management on the long-term survival rate and life quality of liver transplanted patients.Methods374 liver transplant patients who were admitted to the Armed Police General Hospital from January2006 January2009 were analyzed retrospectively. All participants in this study signed written informed consent and consistently in accord with ethical or legal standards. 374 patients were randomly divided into the health model intervention group and the routine follow-up group. The health model intervention group was taken educational intervening during follow up and the routine group was not. The incidences of adverse events were compared between the two groups.Results The incidences of postoperative adverse events were of statistically significant difference in these two groups(17.4% vs.52.2%,χ2=8.326, P<0.05).Conclusion Individualized health management can improve long-term survival rate and life quality of liver transplant patients.
出处
《实用器官移植电子杂志》
2015年第3期146-148,共3页
Practical Journal of Organ Transplantation(Electronic Version)
关键词
肝移植
随访
个体化健康管理
Liver transplantation
Follow-up
Individualized health management
